SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-005577
Filing Date
2018-07-31
Accepted
2018-07-31 17:28:35
Documents
65
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_073118p.htm 10-Q 402021
2 EXHIBIT 10.1 exh_101.htm EX-10.1 135691
3 EXHIBIT 31.1 exh_311.htm EX-31.1 8995
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9014
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3352
12 GRAPHIC exh101_1.jpg GRAPHIC 2170
  Complete submission text file 0001171843-18-005577.txt   3079250

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE anik-20180630.xml EX-101.INS 533452
7 XBRL SCHEMA FILE anik-20180630.xsd EX-101.SCH 43168
8 XBRL CALCULATION FILE anik-20180630_cal.xml EX-101.CAL 35154
9 XBRL DEFINITION FILE anik-20180630_def.xml EX-101.DEF 268676
10 XBRL LABEL FILE anik-20180630_lab.xml EX-101.LAB 216304
11 XBRL PRESENTATION FILE anik-20180630_pre.xml EX-101.PRE 288460
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 18982141
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services